145 related articles for article (PubMed ID: 8209855)
1. In vitro bromodeoxyuridine labeling of malignant neoplasms. A comparative study with flow cytometry cell-cycle analysis.
Lloveras B; Garin-Chesa P; Myc A; Melamed M
Am J Clin Pathol; 1994 Jun; 101(6):703-7. PubMed ID: 8209855
[TBL] [Abstract][Full Text] [Related]
2. A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors.
Waldman FM; Chew K; Ljung BM; Goodson W; Hom J; Duarte LA; Smith HS; Mayall B
Mod Pathol; 1991 Nov; 4(6):718-22. PubMed ID: 1724086
[TBL] [Abstract][Full Text] [Related]
3. Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytology specimens.
ten Velde GP; Schutte B; Reijnders MM; Bosman FT; Blijham GH
Cytometry; 1989 Nov; 10(6):807-10. PubMed ID: 2582973
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
[TBL] [Abstract][Full Text] [Related]
5. [Flow cytometric analysis of cell proliferation kinetics using the anti-BrdUrd antibody].
Sasaki K; Murakami T; Takahashi M
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2338-44. PubMed ID: 2751315
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle perturbation by sodium butyrate in tumorigenic and non-tumorigenic human urothelial cell lines assessed by flow cytometric bromodeoxyuridine/DNA analysis.
Larsen JK; Christensen IJ; Kieler J
Cell Prolif; 1995 Jul; 28(7):359-71. PubMed ID: 7548438
[TBL] [Abstract][Full Text] [Related]
7. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
[TBL] [Abstract][Full Text] [Related]
9. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Vindelov et al. and bromodeoxyuridine/DNA double-staining flow cytometry methods for analysis of cell cycle distribution in rat thymocytes.
Orfao A; Carbajo S; Dolbeare F; Ciudad J; Lopez A; Carbajo-Perez E
Cytometry; 1996 Sep; 25(1):104-8. PubMed ID: 8875060
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry as a tool for the prognostic assessment of human neoplasia.
Mauro F; Teodori L; Schumann J; Göhde W
Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):625-36. PubMed ID: 3700167
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle analysis of synchronized Chinese hamster cells using bromodeoxyuridine labeling and flow cytometry.
Bussink J; Terry NH; Brock WA
In Vitro Cell Dev Biol Anim; 1995; 31(7):547-52. PubMed ID: 8528504
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation in colorectal adenocarcinomas: comparison between Ki-67 immunostaining and bromodeoxyuridine uptake detected by immunohistochemistry and flow cytometry.
Le Pessot F; Michel P; Paresy M; Lemoine F; Hellot MF; Paillot B; Scotte M; Peillon C; Hemet J
Pathol Res Pract; 2001; 197(6):411-8. PubMed ID: 11432668
[TBL] [Abstract][Full Text] [Related]
14. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric bromodeoxyuridine/DNA analysis of hyperthermia and/or adriamycin for human pancreatic adenocarcinoma cell line Capan-2.
Nakata B; Chung YS; Yokomatsu H; Sawada T; Kubo T; Kondo Y; Satake K; Sowa M
Jpn J Cancer Res; 1992 May; 83(5):477-82. PubMed ID: 1618697
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous cell kinetics in tumors analyzed with a simulation model for bromodeoxyuridine single and multiple labeling.
Baisch H; Otto U; Hatje U; Fack H
Cytometry; 1995 Sep; 21(1):52-61. PubMed ID: 8529471
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67.
Goodson WH; Moore DH; Ljung BM; Chew K; Mayall B; Smith HS; Waldman FM
Breast Cancer Res Treat; 2000 Jan; 59(2):113-23. PubMed ID: 10817346
[TBL] [Abstract][Full Text] [Related]
18. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
[TBL] [Abstract][Full Text] [Related]
19. S-phase arrest of nutrient deprived lung cancer cells.
Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
Cytometry; 1995 Apr; 19(4):326-33. PubMed ID: 7796697
[TBL] [Abstract][Full Text] [Related]
20. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
